Medically reviewed by Dr. Pamela Frank, BSc(Hons), ND – Updated July 2026
Fertility After 40 Is Not a Dead End
The fertility narrative around women over 40 is dominated by statistics presented without context: declining egg reserves, rising miscarriage rates, falling IVF success rates per cycle. These numbers are real. They are also incomplete.
What they don’t capture is that fertility decline is not uniform across all women at 40, that most of the biological mechanisms driving age-related fertility decline are at least partially modifiable, and that the distinction between chronological age and reproductive biological age is clinically meaningful. A 42-year-old with optimal thyroid function, low oxidative stress, adequate nutritional reserves, and well-regulated insulin metabolism is reproductively different from a 42-year-old with subclinical hypothyroidism, insulin resistance, vitamin D deficiency, and years of oxidative accumulation – even though they share a birth year.
I gave birth to my son at 41. I don’t present that as a treatment claim – I present it as context for why I take fertility over 40 seriously as a clinical problem with real solutions, rather than a statistical inevitability to be managed down.
I have worked with women over 40 pursuing natural conception, IUI, IVF with their own eggs, and IVF with donor eggs for 26 years. My approach is the same in each case: identify every modifiable factor that is working against you, correct it systematically, and give the next cycle – whether natural or assisted – the best possible biological foundation to work with.
What Actually Happens to Fertility After 40
Understanding the mechanisms helps clarify what is and isn’t addressable.
Oocyte quantity declines
Women are born with their full complement of primordial follicles – approximately 1–2 million at birth – and lose them continuously through a process called atresia. By puberty, approximately 300,000–400,000 remain; by 40, this number has fallen substantially. AMH and antral follicle count reflect this decline. What they don’t reflect is the quality of the remaining follicles, which is a separate, more modifiable variable.
Oocyte quality declines – but this is where naturopathic intervention has the most leverage
The primary driver of age-related oocyte quality decline is mitochondrial dysfunction and accumulated oxidative stress.1 Mitochondria in aging oocytes produce less ATP, generate more reactive oxygen species, and are less able to support the energy-intensive processes of meiosis, fertilization, and early embryo cleavage. This is why chromosomal abnormalities in eggs increase substantially with age – the meiotic spindle assembly process that separates chromosomes requires mitochondrial energy, and when mitochondrial function is compromised, errors accumulate.
Mitochondrial function is modifiable. Oxidative stress is modifiable. Not completely, and not to the level of a 25-year-old – but meaningfully, in ways that affect the probability of producing a chromosomally normal egg in a given cycle.
The hormonal environment shifts
FSH rises as the pituitary works harder to recruit follicles from a smaller pool. Estrogen in the follicular phase may become erratic. The luteal phase may shorten as corpus luteum function declines. Thyroid function, adrenal reserve, and insulin sensitivity all change with age in ways that affect reproductive hormone signalling. These are hormonally complex changes – but each component is measurable, and most are addressable.
The uterine environment is relatively age-independent
This is an important clinical distinction. Endometrial receptivity in women over 40 is largely preserved, as evidenced by substantially higher success rates with donor-egg IVF than with autologous IVF using their own eggs. The limiting factor in most cases is egg quality and chromosomal normalcy, not uterine function. This means interventions targeting endometrial receptivity – uterine blood flow, vitamin D, immune regulation, methylation – remain fully relevant in this age group.
What I Investigate For Fertility Over 40
Standard fertility over 40 workup for women typically includes AMH, antral follicle count, day 3 FSH and estradiol, and uterine ultrasound. My workup goes considerably further because the modifiable contributors to fertility decline in this age group are rarely captured by standard testing.
Full thyroid panel – TSH, free T3, free T4, reverse T3, anti-TPO, anti-thyroglobulin antibodies:
Subclinical hypothyroidism and thyroid autoimmunity both increase in prevalence with age, and both independently impair fertility and increase miscarriage risk. TSH above 2.5 mIU/L is associated with reduced implantation rates and higher miscarriage risk – the standard laboratory reference range upper limit of 4.0–5.0 mIU/L is not the appropriate fertility target.2 Anti-thyroid antibodies are independently associated with pregnancy loss even when TSH is entirely normal.
DHEA-S:
Adrenal DHEA production declines significantly with age – levels at 40 are approximately half what they were at 25. Low DHEA-S is associated with diminished ovarian reserve and reduced response to IVF stimulation. Measuring it identifies women for whom DHEA supplementation is appropriate – without testing, DHEA prescribing is clinically blind.3
Fasting insulin and HOMA-IR:
Insulin resistance becomes more prevalent with age and is directly associated with impaired follicular development, elevated androgens, and altered endometrial receptivity. These are not measured in the standard fertility over 40 workup.
Vitamin D (25-OH):
Vitamin D deficiency is highly prevalent in women over 40 in Ontario and is independently associated with reduced IVF success rates, diminished ovarian reserve, and impaired endometrial receptivity.4 The target for fertility is 100–150 nmol/L – well above what most Ontario labs flag as deficient.
Ferritin:
Iron deficiency without anemia – ferritin below 30 mcg/L – impairs oocyte quality and endometrial oxygen delivery and is missed when only hemoglobin is measured.
Homocysteine and MTHFR status:
Methylation efficiency declines with age. Elevated homocysteine above 10 μmol/L is associated with both implantation failure and miscarriage through effects on trophoblast function and vascular development – directly relevant in a population where miscarriage rates are already elevated.
Prolactin:
Subclinical hyperprolactinemia impairs luteal function and is more prevalent with age, particularly in the context of chronic stress, which accumulates alongside other physiological changes.
Full hormonal panel:
FSH, LH, estradiol (day 3), progesterone (7 days post-ovulation), testosterone, androstenedione, DHT, DHEA-S, cortisol – to identify the specific hormonal contributors to cycle irregularity or luteal phase shortening where present.
Anti-phospholipid antibodies:
Antiphospholipid syndrome becomes more clinically relevant as miscarriage rates rise with age. Women over 40 who experience pregnancy loss should be tested before another conception attempt. Naturopathic doctors in Ontario cannot order this test.
Naturopathic Treatment for Fertility Over 40
Egg Quality – The Primary Target
This is where the most clinically meaningful intervention is possible in women over 40, and it requires a minimum three-month preparation window because oocytes begin their maturation cycle approximately 90 days before ovulation or retrieval.
CoQ10 (ubiquinol, 400–600 mg/day):
The most evidence-based intervention for age-related decline in oocyte quality. CoQ10 is the rate-limiting cofactor in mitochondrial ATP production – and mitochondrial insufficiency is the central mechanism of age-related egg quality decline. A 2018 RCT demonstrated that CoQ10 pretreatment improved ovarian response, mature oocyte yield, fertilization rate, and high-quality embryo rate in women with diminished ovarian reserve.5 The ubiquinol form has superior bioavailability to ubiquinone and is preferred in women over 35. Doses at the higher end of the range are generally used for women struggling with fertility over 40.
Melatonin (1–3 mg at bedtime):
Follicular fluid melatonin is the primary antioxidant protecting the developing oocyte from reactive oxygen species during folliculogenesis. Melatonin production declines with age, and with certain lifestyle habits – as does follicular fluid melatonin concentration – making supplementation directly relevant in this age group. RCT evidence demonstrates that melatonin supplementation improves fertilization rates and the proportion of high-quality embryos in women undergoing IVF.6 It also supports circadian rhythm and sleep quality, both of which influence reproductive hormone pulsatility.
DHEA (25–75 mg/day):
For women over 40 with low or low-normal DHEA-S, DHEA supplementation supports androgen priming of granulosa cells, thereby improving FSH receptor sensitivity and follicular response. A systematic review of 17 studies found DHEA pretreatment was associated with improved ovarian response and live birth rates in poor responders to IVF stimulation.3 DHEA is not appropriate for all women – it can exacerbate androgen excess in women with PCOS – and requires measured DHEA-S levels before initiating and monitoring during treatment. Naturopathic doctors in Ontario cannot prescribe DHEA treatment; this is a discussion for your reproductive endocrinologist.
Vitamin E (mixed tocopherols, 400–800 IU/day):
Protects oocyte cell membranes from lipid peroxidation – a primary mechanism of oxidative damage in aging eggs. Also improves uterine blood flow through nitric oxide-dependent vasodilation of uterine arteries, supporting both egg development and endometrial receptivity.
N-acetylcysteine (NAC, 600 mg/day):
NAC is a glutathione precursor and supports antioxidant defence in the follicular microenvironment. Particularly relevant where oxidative stress is a dominant contributor to poor egg quality.
Alpha-lipoic acid:
A uniquely versatile antioxidant that is both water- and fat-soluble, it regenerates other antioxidants, including vitamins C and E and glutathione, and crosses mitochondrial membranes – making it directly relevant to mitochondrial protection in aging oocytes.
Vitamin C (500–1000 mg/day):
Synergistic antioxidant with vitamin E; supports collagen synthesis, which is relevant to follicular wall integrity and early placentation.
Full details on egg quality interventions are on the egg quality page →.
Ovarian Reserve and Stimulation Response
Low AMH and poor ovarian response to stimulation are common concerns for women struggling with fertility over 40. The following directly addresses this:
DHEA pretreatment (as above):
The evidence base is specifically strongest for poor responders and women with low ovarian reserve, which is the typical presentation in women over 40 pursuing IVF. Always measure and monitor DHEA-S levels. Naturopathic doctors in Ontario cannot prescribe DHEA treatment.
Vitamin D optimization:
Vitamin D receptors on granulosa cells directly influence FSH receptor sensitivity and follicular development. Correcting deficiency before stimulation begins – targeting 100–150 nmol/L – is one of the most impactful and accessible interventions before an IVF cycle.4
Testosterone priming:
Some reproductive endocrinologists use transdermal testosterone in poor responders before stimulation to increase antral follicle sensitivity to gonadotropins. This is a medical intervention outside naturopathic scope – worth discussing with your RE if you have had previous poor ovarian response.
Optimizing thyroid function:
Hypothyroidism and thyroid autoimmunity reduce granulosa cell sensitivity to gonadotropins. Correcting thyroid function – ensuring TSH below 2.5 mIU/L and reducing antibody titers where possible – improves the ovarian response the stimulation protocol has to work with.
Full details on low AMH are on the low AMH page →.
Hormonal Environment and Cycle Regulation
Correcting luteal phase insufficiency:
The luteal phase tends to shorten with age as corpus luteum function declines. A 7-day post-ovulation progesterone level below 40 nmol/L indicates inadequate luteal support. Vitex agnus-castus, vitamin B6, magnesium, and correction of the underlying hormonal drivers – prolactin, thyroid, insulin – address this directly.7
Reducing prolactin:
Mildly elevated prolactin – below what most labs flag as abnormal – is sufficient to shorten the luteal phase and impair implantation. Vitex agnus-castus has the most consistent evidence for reducing subclinical hyperprolactinemia in this context.
Correcting insulin resistance:
Where present, insulin resistance elevates androgens, disrupts LH:FSH ratios, impairs endometrial receptivity, and increases miscarriage risk. Dietary modification plus inositol or berberine (pre-conception only) addresses this directly and produces measurable improvements in cycle regularity and hormonal balance.
Adrenal support:
CRH-mediated suppression of GnRH pulsatility from chronic HPA axis activation becomes more clinically significant in women over 40 who have typically accumulated more cumulative stress. Adaptogenic herbs – schisandra, centella, ashwagandha (Withania somnifera) for HPA axis regulation, under appropriate clinical assessment – nutritional adrenal support (B vitamins, vitamin C, magnesium and zinc), and sleep optimization directly support hypothalamic-pituitary-ovarian axis function.
Endometrial Receptivity
As noted above, the uterine environment is largely age-independent. This means all interventions supporting endometrial receptivity remain fully relevant:
Uterine blood flow:
Vitamin E and L-arginine improve radial artery blood flow and endometrial thickness through complementary nitric oxide-dependent mechanisms – covered in detail on the thin uterine lining page →.
Omega-3 fatty acids (2g EPA/DHA daily):
Omega-3 fatty acids support prostaglandin balance, uterine vascular development, and endometrial immune regulation.
Methylation support:
5-MTHF, methylcobalamin, and P5P ensure adequate methylation for normal endometrial cell proliferation and trophoblast function. Homocysteine normalization is a specific target – elevated homocysteine is associated with implantation failure and pregnancy loss and becomes more common with age.
Vitamin D:
Vitamin D has direct effects on endometrial stromal and glandular cell function, uterine NK cell regulation, and decidualization – all relevant to implantation success regardless of age. Always measure, adjust the dose accordingly, and repeat testing in 3 months to ensure vitamin D optimization (100-150 nmol/L).
Miscarriage Risk Reduction
Miscarriage rates in women hoping for fertility over 40 are substantially higher than in younger women – approximately 40–50% of recognized pregnancies at 42–44 – primarily reflecting chromosomal aneuploidy in aging oocytes.8 The naturopathic approach targets what is modifiable:
Reducing chromosomal aneuploidy through mitochondrial support:
CoQ10 and the broader antioxidant protocol reduce the oxidative DNA damage in oocytes that contributes to meiotic errors. This does not eliminate age-related aneuploidy – some of that risk reflects fundamental biology – but reduces the modifiable portion of it.
Antiphospholipid antibody testing:
Women over 40 who experience pregnancy loss should be tested for APS before the next attempt. Untreated APS is correctable; missing it is a preventable cause of repeated loss. Naturopathic doctors in Ontario cannot order this test.
Thyroid optimization:
Anti-thyroid antibodies and subclinical hypothyroidism are both more prevalent in women struggling with fertility over 40, and both independently increase miscarriage risk. This is one of the highest-value investigations in this population.
Methylation support:
Homocysteine elevation – more common with age – is independently associated with early pregnancy loss. Correction with methylated B vitamins is straightforward and directly targets this mechanism.
Progesterone support:
Luteal phase inadequacy – more common in older women as corpus luteum function declines – is a correctable cause of early pregnancy loss. Vitex, B6, magnesium, and correction of upstream hormonal drivers support luteal adequacy.
Full details on miscarriage prevention are on the recurrent miscarriage page →.
IVF With Own Eggs vs. Donor Eggs: Where Naturopathic Support Fits
Women over 40 pursuing IVF face a decision that their reproductive endocrinologist will raise: continuing with their own eggs versus transitioning to donor eggs. This is a medical and personal decision, not a naturopathic one, and I do not advise on it. What I can offer is:
For women pursuing IVF with their own eggs:
The three-month preparation protocol targeting egg quality, ovarian response, and endometrial receptivity gives each retrieval cycle the best possible biological foundation. This is particularly important when egg numbers are limited – optimizing the quality of whatever eggs are retrieved maximizes the probability that at least one will be chromosomally normal and developmentally competent.
For women using donor eggs:
Egg quality is no longer the limiting factor. Endometrial receptivity becomes the primary target. The full protocol for endometrial preparation – uterine blood flow, vitamin D, omega-3s, methylation support, immune regulation – is directly relevant and fully within naturopathic scope. Many women find that comprehensive endometrial preparation before a donor egg transfer is where naturopathic care adds the most value.
For women pursuing natural fertility over 40:
The same preparation principles apply, with the addition of cycle monitoring to identify the specific days of maximum fertility and to detect any luteal phase or ovulatory irregularities that can be addressed. Natural fertility over 40 is less common than at younger ages, but is not rare – it requires that the conditions for it are optimized, not just hoped for.
Full details on IVF preparation are on the IVF/IUI support page →.
What to Realistically Expect
This section is deliberately honest because false hope and dismissive pessimism are both poor clinical approaches.
Naturopathic medicine cannot restore a depleted ovarian reserve to youthful levels, reverse chromosomal aneuploidy in existing eggs, or eliminate the biological reality that fertility over 40 declines due to age. Anyone claiming otherwise is not being truthful.
What naturopathic medicine can do is ensure that every cycle – natural or assisted – is undertaken with the best possible biological preparation. The mitochondria in the remaining eggs are as functional as possible. The hormonal environment supports normal folliculogenesis and luteal adequacy. The uterine environment is as receptive as possible. The inflammatory and metabolic burden is minimized. Nutritional reserves are optimal. These are meaningful differences that affect real outcomes – they are just not guarantees.
The honest framework is: naturopathic preparation increases the probability of a good outcome in any given cycle. In a population where the baseline probability per cycle is already low, meaningfully increasing that probability is clinically significant.
Frequently Asked Questions About Fertility Over 40
Can I get pregnant naturally at 40 or over?
Yes, natural conception after 40 is possible and occurs regularly. Fertility over 40 does decline due to age – the monthly probability of conception is lower at 42 than at 32 – but it is not zero, and it varies significantly between individuals depending on ovarian reserve, hormonal balance, and overall health. Women with well-preserved ovarian reserve, optimal thyroid function, low oxidative stress, and good metabolic health are reproductively different from women of the same age with multiple untreated modifiable contributors to fertility over 40 decline.
Is IVF less likely to work after 40 with my own eggs?
Yes – IVF success rates per cycle with own eggs decline with maternal age, primarily because chromosomal aneuploidy rates in eggs increase with age. Preimplantation genetic testing for aneuploidy (PGT-A) can identify chromosomally normal embryos for transfer, which substantially improves implantation rates per transfer even in older women. Donor egg IVF has significantly higher per-transfer success rates in women over 40 than autologous IVF, because donor eggs are typically from younger women with lower aneuploidy rates. These are conversations to have with your reproductive endocrinologist.
What supplements are most important for fertility over 40?
The evidence base most strongly supports CoQ10 (ubiquinol) for oocyte mitochondrial function, melatonin for follicular antioxidant defence, vitamin D for ovarian and endometrial function, and omega-3 fatty acids for prostaglandin balance and uterine perfusion. DHEA is relevant for women with low DHEA-S and poor ovarian response but is not appropriate for all women. The appropriate combination and doses depend on your specific test results and history – a generic supplement protocol is rarely optimal for fertility over 40.
How long does it take to see improvement in egg quality?
A minimum of three months, reflecting the full oocyte maturation cycle. Eggs ovulated or retrieved in a cycle that begins in October start their maturation process in July, which is why interventions started the week before retrieval don’t influence the eggs being collected. Starting preparation three months before a planned cycle is the minimum; starting earlier when possible gives more runway.
Does low AMH mean I can’t get pregnant over 40?
Low AMH reflects a reduced egg quantity but does not directly measure egg quality or predict individual fertility over 40 outcomes in natural conception. A 2017 study published in JAMA found that among women attempting natural conception, AMH levels were not associated with the probability of conception in a given cycle.9 AMH is most meaningful in the context of IVF, where ovarian response to stimulation determines how many eggs can be retrieved. Low AMH in the context of IVF means fewer eggs retrieved per cycle – but a smaller number of high-quality eggs is clinically more valuable than a larger number of chromosomally abnormal ones.
Should I see a naturopath or a reproductive endocrinologist if I’m over 40 and trying to conceive?
Both. A reproductive endocrinologist assesses your ovarian reserve, identifies structural or hormonal abnormalities requiring medical management, and coordinates assisted reproduction if that is the path you choose. A naturopathic doctor identifies modifiable contributors that standard workup doesn’t capture, optimizes egg quality and endometrial receptivity in the preparation period, and supports you through natural or assisted conception attempts. These roles are complementary – one does not replace the other.
Is it too late to start naturopathic preparation if my IVF cycle is already scheduled?
Starting now is always better than not starting. Even a shorter preparation window – 6 weeks rather than 3 months – allows time to correct acute nutritional deficiencies, reduce oxidative stress markers, and ensure thyroid function is optimized before stimulation begins. The earlier you start, the greater the benefit to the oocytes currently in maturation, but partial optimization is meaningful even when the timeline is compressed.
Fertility Over 40 Research References
- Tilly JL, Sinclair DA. Germline energetics, aging, and female infertility. Cell Metab. 2013 Jun 4;17(6):838-850. doi: 10.1016/j.cmet.2013.05.007. PMID: 23747243; PMCID: PMC3756096.
- Alexander EK, Pearce EN, Brent GA, Brown RS, Chen H, Dosiou C, Grobman WA, Laurberg P, Lazarus JH, Mandel SJ, Peeters RP, Sullivan S. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. Thyroid. 2017 Mar;27(3):315-389. doi: 10.1089/thy.2016.0457. Erratum in: Thyroid. 2017 Sep;27(9):1212. doi: 10.1089/thy.2016.0457.correx. PMID: 28056690.
- Nagels HE, Rishworth JR, Siristatidis CS, Kroon B. Androgens (dehydroepiandrosterone or testosterone) for women undergoing assisted reproduction. Cochrane Database Syst Rev. 2015 Nov 26;2015(11):CD009749. doi: 10.1002/14651858.CD009749.pub2. Update in: Cochrane Database Syst Rev. 2024 Jun 5;6:CD009749. doi: 10.1002/14651858.CD009749.pub3. PMID: 26608695; PMCID: PMC10559340.
- Chen Y, Zhi X. Roles of Vitamin D in Reproductive Systems and Assisted Reproductive Technology. Endocrinology. 2020 Apr 1;161(4):bqaa023. doi: 10.1210/endocr/bqaa023. PMID: 32067036.
- Xu Y, Nisenblat V, Lu C, Li R, Qiao J, Zhen X, Wang S. Pretreatment with coenzyme Q10 improves ovarian response and embryo quality in low-prognosis young women with decreased ovarian reserve: a randomized controlled trial. Reprod Biol Endocrinol. 2018 Mar 27;16(1):29. doi: 10.1186/s12958-018-0343-0. PMID: 29587861; PMCID: PMC5870379.
- Tamura H, Nakamura Y, Korkmaz A, Manchester LC, Tan DX, Sugino N, Reiter RJ. Melatonin and the ovary: physiological and pathophysiological implications. Fertil Steril. 2009 Jul;92(1):328-43. doi: 10.1016/j.fertnstert.2008.05.016. Epub 2008 Sep 18. PMID: 18804205.
- van Die MD, Burger HG, Teede HJ, Bone KM. Vitex agnus-castus extracts for female reproductive disorders: a systematic review of clinical trials. Planta Med. 2013 May;79(7):562-75. doi: 10.1055/s-0032-1327831. Epub 2012 Nov 7. PMID: 23136064.
- Nybo Andersen AM, Wohlfahrt J, Christens P, Olsen J, Melbye M. Maternal age and fetal loss: population based register linkage study. BMJ. 2000 Jun 24;320(7251):1708-12. doi: 10.1136/bmj.320.7251.1708. PMID: 10864550; PMCID: PMC27416.
- Steiner AZ, Pritchard D, Stanczyk FZ, Kesner JS, Meadows JW, Herring AH, Baird DD. Association Between Biomarkers of Ovarian Reserve and Infertility Among Older Women of Reproductive Age. JAMA. 2017 Oct 10;318(14):1367-1376. doi: 10.1001/jama.2017.14588. PMID: 29049585; PMCID: PMC5744252.